Pricing Log in Create free account
Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

CORT Healthcare Biotechnology

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue
+64.0%
EPS
+525.8%
Free cash flow
+161.0%

Quarter to September 2026, against a year earlier

72.87 1.24 +1.73%
Market cap
$7.8B
P/E
47.5×
Fwd P/E
39.8×
Dividend yield
—
F-score
4/9
Altman Z
14.11
Beneish M
−2.76
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Corcept Therapeutics Incorporated (CORT) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Corcept Therapeutics Incorporated (CORT) trades at a EV/FCF of 37.7×. Over the past ten years it has ranged from −233× (December 2015) to 166× (December 2015); the current reading is higher than 72% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.0× (6.81%)
FY2024 24.7× 45.43%
FY2023 17.0× 17.29%
FY2022 14.5× 16.49%
FY2021 12.4× (27.78%)
FY2020 17.2× 107.15%
FY2019 8.3× (29.04%)
FY2018 11.7× (64.37%)
FY2017 32.8× (23.56%)
FY2016 42.9× (74.21%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 61.3× (26.10%)
Jun 2026 83.0× 156.42%
Mar 2026 32.4× 40.81%
Dec 2025 23.0× (54.24%)
43 more quarters

Against its own ten years

Low −233× High 166×
Ten-year median 17.4×
Current reading's percentile 70

EV/FCF against peers

Company EV/FCF
ARWR Arrowhead Pharmaceuticals, Inc. compare −100×
MDGL Madrigal Pharmaceuticals, Inc. compare −64.5×
SYRE Spyre Therapeutics, Inc. compare −30.3×
ABVX Abivax SA Sponsored ADR compare −27.7×
PRAX Praxis Precision Medicines, Inc. compare −22.7×
CYTK Cytokinetics, Incorporated compare −12.7×
KRYS Krystal Biotech, Inc. compare 25.7×
CORT Corcept Therapeutics Incorporated 37.7×
PTGX Protagonist Therapeutics, Inc. compare 62.4×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on CORT